Requires the Secretary of Health and Human Services to establish drug adherence guidelines using artificial intelligence and machine learning, aiming for 90% adherence for Medicare Part B and D drugs. Promotes usage of generic and biosimilar drugs.
Analysis summaries, actor details, and coverage mappings were LLM-classified and may contain errors.
This is a proposed federal statute with mandatory language requiring the Secretary of Health and Human Services to establish drug adherence guidelines. It uses binding legal language ('shall establish', 'shall incorporate') and would create enforceable legal obligations once enacted.
This document has minimal risk domain coverage, with only brief implicit references to AI system safety concerns through the mandate to use AI/ML technologies for drug adherence. The primary focus is on healthcare policy and drug adherence rather than AI risk mitigation.
This bill primarily governs the Health Care and Social Assistance sector by mandating AI-enabled drug adherence guidelines for Medicare. It also has implications for the Information sector through the requirement to incorporate AI/ML technologies, and potentially affects the Finance and Insurance sector given Medicare's role in healthcare financing.
The document primarily addresses the deployment and operational monitoring stages of AI systems, as it mandates the incorporation of AI/ML technologies into drug adherence guidelines and sets a specific performance goal (90% adherence) that would require ongoing monitoring. There is minimal coverage of earlier lifecycle stages.
The document mentions AI and machine learning technologies in general terms but does not specify particular types of AI systems, models, or technical thresholds. It does not distinguish between different AI categories such as general purpose, task-specific, generative, or predictive AI.
United States Congress; Senate and House of Representatives of the United States of America
The document is a congressional bill proposed by the U.S. Congress, as indicated by the standard legislative format and enacting clause.
Secretary of Health and Human Services; Department of Health and Human Services
The Secretary of HHS is given the authority to establish and presumably enforce the drug adherence guidelines through the Department's regulatory powers.
Secretary of Health and Human Services
While not explicitly stated, the Secretary of HHS would be responsible for monitoring achievement of the 90% adherence goal as the entity establishing the guidelines.
Secretary of Health and Human Services; Medicare Part B and D drug providers
The bill targets the Secretary of HHS who must establish guidelines, and implicitly targets entities involved in Medicare drug provision who would need to comply with the 90% adherence goal. The requirement to incorporate AI/ML technologies suggests AI developers in healthcare may also be targets.